Vancouver, Canada

Jan Peter Bergqvist

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 6.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Mind of Jan Peter Bergqvist

Introduction

Jan Peter Bergqvist is a notable inventor based in Vancouver, Canada. He has contributed significantly to the field of biotechnology, holding a total of four patents related to cancer treatment and immunology. His inventiveness showcases the impact of scientific research on medical advancements.

Latest Patents

One of Jan's latest patents is titled "Anti-podocalyxin antibodies and methods of using the same." This invention focuses on anti-podocalyxin antibodies, compositions incorporating these antibodies, and various methods for their use in preventing, diagnosing, and treating cancer. Another important patent is "Anti-HLA-A2 antibodies and methods of using the same," which features humanized anti-HLA-A2 antibodies capable of forming an antigen-binding domain of a chimeric antigen receptor (CAR). These CARs can be expressed in human cells, allowing them to bind specifically to HLA-A2. The patent also includes applications for modified cells containing these antibodies and CARs, along with methods for utilizing these modified cells in therapies.

Career Highlights

Throughout his career, Jan has been involved with Zymeworks Inc., a company known for its innovative approach to developing therapeutic solutions. His work has significantly influenced the company's research and development in biopharmaceuticals.

Collaborations

Jan Peter Bergqvist has collaborated with esteemed colleagues such as John Stephen Babcook and Calvin D. Roskelley. These collaborations have helped to enhance the research and development impact of their collective work in the field of biotechnology.

Conclusion

Jan Peter Bergqvist exemplifies the spirit of innovation through his groundbreaking patents and collaborations. His contributions to cancer treatment and immunology not only advance scientific knowledge but also hold the potential to improve patient outcomes significantly. As the fields of biotechnology and medicine continue to evolve, inventors like Jan remain at the forefront of innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…